Torsemide tablets bulk supplier for pharma manufacturers

Torsemide Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg, 20 mg, 100 mg

Reference Brands: Demadex(US & EU)

Category: Heart Disorder

Torsemide tablets is available in Tablet and strengths such as 10 mg, 20 mg, 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Torsemide tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Torsemide tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description: Torsemide tablets, marketed as Demadex, are approved in the US by the FDA and in the EU via EMA for edema and hypertension management. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier submission, regulatory pathways, and market access strategies, visit PharmaTradz. Proper regional compliance supports timely approval, safe use, and global availability of torsemide tablets, enabling effective treatment of fluid retention and cardiovascular conditions worldwide.

Frequently Asked Questions

Yes, Torsemide tablets is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Torsemide tablets is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Aliskiren Tablets

Strength: 150 mg, 300 mg

Form: Tablets

Reference Brands: Tekturna(US & EU)

View Details
Atenolol Tablets

Strength: 25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Tenormin(US)

View Details
Metoprolol Tartrate Tablet

Strength: IR: 25 mg, 50 mg, 100 mg; ER: 25 mg, 50 mg, 100 mg, 200 mg

Form: Tablets(IR & ER)

Reference Brands: US: Lopressor(IR); Toprol-XL(ER)

View Details
Nifedipine Tablets(Ir/Er)

Strength: 10 mg, 20 mg, 30 mg, 60 mg, 90 mg (IR and ER forms)

Form: Tablet(IR & ER)

Reference Brands: Procardia(US);

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.